Anticoagulation Forum: View patient education and many more resources from the largest peer organization of anticoagulation providers in the nation. Additional resources at the Anticoagulation Centers of Excellence.
Blood Thinner Pills: Your Guide to Using Them Safely: Patient education resources for safe use of anticoagulants from the Agency for Health Research and Quality
Anticoagulation Toolkit: Thorough resource from Michigan Anticoagulation Quality Improvement Initiative covering anticoagulation management and recommendations for warfarin and direct oral anticoagulants (DOACs).
Lower Costs and Shorter Length of Stay for Afib Patients using Novel Oral Anticoagulant vs Warfarin: No change in readmission rates, but shorter hospital stays and savings noted. Further savings can be achieved by avoiding unnecessary bridge therapy when initiating NOACs.
FDA Approves First Novel Oral Anticoagulant Reversal Agent: Praxbind (idarucizumab, Boehringer Ingelheim) granted accelerated approval to rapidly reverse the blood-thinning effects of the anticoagulant Pradaxa (dabigatran, Boehringer Ingelheim).